Bromelain Market Overview by Business Prospects and Forecast 2030
Bromelain Market Scope
Bromelain market 2022 is all set to touch USD 1,154.4 million
by 2030, suggests the latest study by MRFR (Market Research Future. MRFR also
expects the market’s growth rate to be 4.39 % over the review period (between
2022 and 2030). We will provide COVID-19 impact analysis with the report, along
with all the extensive key developments in the market post the coronavirus
disease outbreak.
Top Boosters and Challenges
The escalating disposable income and the amplified number of
end-users in the global bromelain
market size can result in significant business growth during the evaluation
period. One such end-user is the cosmetics industry, which has been integrating
bromelain as a key ingredient in various formulations. Besides, the market has
also been bolstered by the strong demand for natural ingredients and the surge
in the setting up of various biorefinery plants across the world. Skincare
products containing bromelain are used extensively around the world, mainly to
reduce acne, dry skin and wrinkles. On the other hand, the seafood and meat
industry also makes widespread demand for the target product, for improving the
tenderness of pork, beef, squids and chicken.
Growth of industries like bakery, dietary supplements,
beverage and cosmetics as key end-users for bromelain in countries such as
Indonesia, the U.S., France, Germany, India, South Africa, Brazil and China can
translate into heightened product demand in the years to come. Bromelain’s use in
the healthcare industry has been increasing at a promising rate, given the
intense R&D activities to expand the product’s application scope for the
treatment of HIV, cancer and inflammatory diseases such as coeliac disease,
asthma, glomerulonephritis, hepatitis, as well as autoimmune diseases.
It is expected that the heightened demand for bromelain in
the health care industry can offer attractive opportunities to the market
leaders in the years to come. Intense R&D activities being conducted by
renowned firms to boost the application scope of bromelain, especially in the
healthcare industry, is working in the market’s favor. To cite a reference, in
September 2020, researchers combined anthocyanin-rich extracts derived from
tart cherry and hawthorn berries with bromelain extracted from pineapple, to
showcase that the end result can help enhance the endothelial function and
bring down the systolic blood pressure.
The combination of bromelain and anthocyanin has led to considerable
reductions in the systolic blood pressure in the recent past.
Leading Vendors
Krishna Enzytech Pvt. Ltd. (India), Advanced Enzyme
Technologies (India), Enzybel Group (Belgium), Fooding Group Limited (China),
Changsha Natureway Co., Ltd. (China), Enzyme Development Corporation (U.S.),
Creative Enzymes (U.S.), Hong Mao Biochemicals Co. Ltd. (Thailand), Nutriteck
(Canada), Food State Company (U.K.), are some of the top vendors in the global
market.
Segmental Review
The bromelain
market overview has been extensively reviewed in the MRFR report, with
source, type, and application considered as key segments for an enhanced
understanding of the latest trends.
Sources mentioned in the report are fruits as well as stems.
The best source is considered to be the stem, which acquired a share of 88% in
the global market in 2017, while fruits managed to seize a share of 12% the same
year. The stems segment can reach a valuation of USD 931.6 million by 2030,
whereas the fruits segment can expand to approximately USD 123.4 million by 2030
at a rate of 4.32%.
The types of bromelain on the market are 1,200 GDU/g, 2,000
GDU/g, 2,500 GDU/g, and more. The 2,000 GDU/g segment can be in the leading
position in the coming years, while the 2,500 GDU/g segment can advance at the
highest rate of 4.94% to reach close to USD 281.3 million by 2030.
The applications of bromelain are healthcare, food and
beverages, dietary supplements, and more. In 2017, the dietary supplements
segment accounted for a share of 39.6% of the market, trailed by healthcare
with a share of 35.6% and food & beverages with a 19.4% share. The other
segment claimed a share of 5.4% in the global industry. The dietary supplement
segment can expand to USD 425.0 million by 2030, and the healthcare segment
will touch USD 378.4 million by the same year. The healthcare segment’s growth
rate is anticipated to be 6.64% between 2020 and 2030.
Regional Insight
Regionally, the bromelain market size has been studied with
respect to North America, Asia Pacific, or APAC, and Europe, along with RoW, or
Rest of the-World.
Since 2017, North America has remained the top-performing
market, with Europe, APAC, and RoW right behind. North America’s formidable
position in the global bromelain market is the outcome of the burgeoning meat
industry and the high uptake of dietary supplements among consumers. The high
uptake of energy-efficient technologies and the escalating number of R&D
activities for the development of high quality products in the region can
present attractive opportunities to the major players. Apart from this, the
soaring use of natural enzymes for developing various medications could also
foster product demand in the years to follow.
Europe has been second highest gainer since 2017, thanks to
the high use of bromelain as a meat tenderizing agent in processed foods and
ready-to-eat products. The escalating use of bromelain in the cosmetics
industry coupled with the extensive adoption as a dietary supplement,
especially in Germany can also benefit the European market.
NOTE: Our Team of Researchers are Studying Covid19 and
its Impact on Various Industry Verticals and wherever required we will be
considering Covid19 Footprints for Better Analysis of Market and Industries.
Cordially get in Touch for More Details.
Contact us:
Market Research Future (part of Wantstats Research and
Media Private Limited),
Comments
Post a Comment